North America Ambulatory Infusion Pumps Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

PUBLISHED: December 1, 2024

PAGES: 200 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The North American ambulatory infusion pumps market is projected to grow from $6.3 billion in 2024 to $11.2 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.6% during 2025-2030. This growth is driven by the increasing prevalence of chronic diseases, a rising geriatric population, and a growing demand for ambulatory services.

Key Insights

By product type, devices include portable and wearable pumps designed for patient mobility. Accessories and consumables such as tubing, catheters, and reservoirs are essential for the operation of infusion devices.

By route of administration, intravenous infusion delivers medication directly into the bloodstream and is widely used for various therapies. Subcutaneous infusion targets the tissue layer between the skin and muscle, often for insulin delivery. Epidural infusion is primarily used for pain management through administration into the spinal cord's epidural space.

By application, pain management utilizes infusion pumps for controlled delivery of analgesics for chronic or acute pain. Diabetes management employs insulin pumps for continuous subcutaneous insulin infusion. Oncology involves controlled chemotherapy drug administration. Neonatology ensures precise delivery of nutrients and medications to newborns. Gastroenterology uses infusion pumps for nutritional or medicinal needs, while general anesthesia and emergency medicine require accurate and rapid medication delivery.

By distribution channel, direct sales are conducted between manufacturers and end-users such as hospitals and clinics, while indirect sales occur through intermediaries, including distributors and retailers.

The United States is the largest and fastest-growing market, driven by a high prevalence of chronic diseases, advanced healthcare infrastructure, and increasing adoption of ambulatory infusion technologies.

Technological advancements include the development of smart infusion pumps with safety features like dose error reduction systems, enhancing patient safety. Wireless connectivity and integration with electronic health records (EHRs) enable real-time monitoring and data sharing. Miniaturization of devices improves patient comfort and mobility, fostering the adoption of ambulatory infusion therapies.

The market is fragmented, with numerous players focusing on product innovation and strategic partnerships to enhance their market presence. Emerging opportunities include the rising demand for home-based infusion therapies due to their cost-effectiveness and convenience. The growing prevalence of diabetes and other chronic conditions presents significant growth potential for insulin pumps and related devices.

Product Code: 12477

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Product Type
- 1.4.2. Market Size Breakdown, by Route of Administration
- 1.4.3. Market Size Breakdown, by Application
- 1.4.4. Market Size Breakdown, by Distribution Channel
- 1.4.5. Market Size Breakdown, by Country
1.5. Market Data Reporting Unit
- 1.5.1. Revenue
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Industry Background
5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
5.3. Impact of COVID-19
5.4. Sociopolitical Impact
5.5. Porter's Five Forces Analysis
- 5.5.1. Bargaining Power of Buyers
- 5.5.2. Bargaining Power of Suppliers
- 5.5.3. Threat of New Entrants
- 5.5.4. Intensity of Rivalry
- 5.5.5. Threat of Substitutes
5.6. Innovation and Technology Trends
5.7. Supply Chain and Value Chain Insights
5.8. Economic and Regulatory Impact
5.9. Market Entry Strategies

Chapter 6. Competitive Landscape

6.1. List of Market Players and their Offerings
6.2. Market Share of Key Players (2024)
6.3. Competitive Benchmarking of Key Players
6.4. Product Benchmarking of Key Players
6.5. Recent Strategic Developments by Key Players
6.6. Company Leadership Matrix

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Product Type (2019-2032)
7.3. Market Revenue, by Route of Administration (2019-2032)
7.4. Market Revenue, by Application (2019-2032)
7.5. Market Revenue, by Distribution Channel (2019-2032)
7.6. Market Revenue, by Country (2019-2032)

Chapter 8. U.S. Market

8.1. Overview
8.2. Economic Indicators
8.3. Demographics and Population Insights
8.4. Regional Hotspots
8.5. Growth Drivers
8.6. Challenges and Barriers
8.7. Competitive Strategies
8.8. Emerging Players
8.9. Import/Export Policies
8.10. Compliance Requirements
8.11. Emerging Investment Areas
8.12. Market Size and Forecast
- 8.12.1. Market Revenue, by Product Type (2019-2032)
- 8.12.2. Market Revenue, by Route of Administration (2019-2032)
- 8.12.3. Market Revenue, by Application (2019-2032)
- 8.12.4. Market Revenue, by Distribution Channel (2019-2032)

Chapter 9. Canada Market

9.1. Overview
9.2. Economic Indicators
9.3. Demographics and Population Insights
9.4. Regional Hotspots
9.5. Growth Drivers
9.6. Challenges and Barriers
9.7. Competitive Strategies
9.8. Emerging Players
9.9. Import/Export Policies
9.10. Compliance Requirements
9.11. Emerging Investment Areas
9.12. Market Size and Forecast
- 9.12.1. Market Revenue, by Product Type (2019-2032)
- 9.12.2. Market Revenue, by Route of Administration (2019-2032)
- 9.12.3. Market Revenue, by Application (2019-2032)
- 9.12.4. Market Revenue, by Distribution Channel (2019-2032)